CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943134940
- Phone
- 4154825300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief R&D Officer sold 5,681 shares at $70.00 ($397,670)
- 144 Insider Sale of Securities
- 4 Planned sale President & CEO sold 20,000 shares at an average $60.75 ($1,215,056)
- 4 Planned sale Chief R&D Officer sold 5,538 shares at $60.71 ($336,212)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Shareholder vote results
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief R&D Officer sold 199 shares at $65.51 ($13,036)
- 4 Open-market sale President & CEO sold 444 shares at $65.51 ($29,086)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Executive or director change
Page 2 of 100 · 1,981 filings